Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články, směrnice pro lékařskou praxi
Grantová podpora
G0800675
Medical Research Council - United Kingdom
MRF_C0482
MRF - United Kingdom
CEP - Centrální evidence projektů
PubMed
24909831
DOI
10.1016/j.crohns.2014.04.005
PII: S1873-9946(14)00148-2
Knihovny.cz E-zdroje
- Klíčová slova
- Crohn's disease, Guidelines, Medical therapy, Pediatric,
- MeSH
- adalimumab MeSH
- algoritmy MeSH
- antibakteriální látky terapeutické užití MeSH
- antiflogistika nesteroidní terapeutické užití MeSH
- azathioprin terapeutické užití MeSH
- Crohnova nemoc terapie MeSH
- dítě MeSH
- enterální výživa * MeSH
- hormony kůry nadledvin škodlivé účinky terapeutické užití MeSH
- humanizované monoklonální protilátky terapeutické užití MeSH
- imunosupresiva terapeutické užití MeSH
- indukce remise metody MeSH
- infliximab MeSH
- kyseliny aminosalicylové terapeutické užití MeSH
- lidé MeSH
- merkaptopurin terapeutické užití MeSH
- methotrexát terapeutické užití MeSH
- mladiství MeSH
- monoklonální protilátky terapeutické užití MeSH
- thalidomid terapeutické užití MeSH
- TNF-alfa antagonisté a inhibitory MeSH
- udržovací chemoterapie metody MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- Publikační typ
- časopisecké články MeSH
- směrnice pro lékařskou praxi MeSH
- Názvy látek
- adalimumab MeSH
- antibakteriální látky MeSH
- antiflogistika nesteroidní MeSH
- azathioprin MeSH
- hormony kůry nadledvin MeSH
- humanizované monoklonální protilátky MeSH
- imunosupresiva MeSH
- infliximab MeSH
- kyseliny aminosalicylové MeSH
- merkaptopurin MeSH
- methotrexát MeSH
- monoklonální protilátky MeSH
- thalidomid MeSH
- TNF-alfa MeSH
Children and adolescents with Crohn's disease (CD) present often with a more complicated disease course compared to adult patients. In addition, the potential impact of CD on growth, pubertal and emotional development of patients underlines the need for a specific management strategy of pediatric-onset CD. To develop the first evidenced based and consensus driven guidelines for pediatric-onset CD an expert panel of 33 IBD specialists was formed after an open call within the European Crohn's and Colitis Organisation and the European Society of Pediatric Gastroenterolog, Hepatology and Nutrition. The aim was to base on a thorough review of existing evidence a state of the art guidance on the medical treatment and long term management of children and adolescents with CD, with individualized treatment algorithms based on a benefit-risk analysis according to different clinical scenarios. In children and adolescents who did not have finished their growth, exclusive enteral nutrition (EEN) is the induction therapy of first choice due to its excellent safety profile, preferable over corticosteroids, which are equipotential to induce remission. The majority of patients with pediatric-onset CD require immunomodulator based maintenance therapy. The experts discuss several factors potentially predictive for poor disease outcome (such as severe perianal fistulizing disease, severe stricturing/penetrating disease, severe growth retardation, panenteric disease, persistent severe disease despite adequate induction therapy), which may incite to an anti-TNF-based top down approach. These guidelines are intended to give practical (whenever possible evidence-based) answers to (pediatric) gastroenterologists who take care of children and adolescents with CD; they are not meant to be a rule or legal standard, since many different clinical scenario exist requiring treatment strategies not covered by or different from these guidelines.
Department of Paediatrics 1 Semmelweis University Bókay János str 53 1083 Budapest Hungary
Department of Paediatrics 460 Hvidovre University Hospital Kettegård Allé 30 2650 Hvidovre Denmark
Department of Paediatrics St Marien Hospital Robert Koch Str 1 53115 Bonn Germany
Department of Pediatrics University Hospital Motol Uvalu 84 150 06 Prague Czech Republic
Gastroenterology and Endoscopy Unit Istituto G Gaslini Via G Gaslini 5 16148 Genoa Italy
Gastroenterology Sheba Medical Center 52621 Tel Hashomer Israel
Unit of Paediatric Gastroenterology Hospital S João A Hernani Monteiro 4202 451 Porto Portugal
Citace poskytuje Crossref.org
Intestinal tissue levels of anti-TNF alpha, antibodies, and cytokines in paediatric Crohn disease
Kono-S anastomosis in Crohn's disease: initial experience in pediatric patients
Prediction of thiopurine failure in pediatric Crohn's disease: pediatric IBD Porto group of ESPGHAN
Comparison of laparoscopic and open ileocecal resection for Crohn's disease in children
Infliximab in young paediatric IBD patients: it is all about the dosing